Organisation paid for research Program year 2023 Source: CMS Open Payments

Albemarle Clinical Trials, LLC

Neither a doctor nor a teaching hospital

Research payments

$59,154

37 payments

Through program year 2023, Albemarle Clinical Trials, LLC is reported as receiving $59,154 in research payments, across 37 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$5,255	6
2022	Research	$21,305	12
2021	Research	$2,630	2
2020	Research	$10,791	7
2019	Research	$19,173	10

Breakdown

Who paid Research payments · program years 2019–2023

Glaukos Corporation $59,154 37 payments

Studies the money was for Research payments · program years 2019–2023

A Prospective, Randomized, Controlled, Parallel Groups, Multicenter Post-Approval Study of the Glaukos iStent Trabecular Micro-Bypass Stent System in Conjunction with Cataract Surgery $32,594 19 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $5,255 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.